NCT05840159View on ClinicalTrials.gov

A Study of Doxycycline to Treat Chlamydial Infection

PHASE4RecruitingINTERVENTIONAL
Enrollment

664

Participants

Timeline

Start Date

January 19, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Chlamydial Infection
Interventions
DRUG

Doxycycline

Doxycycline is a synthetic tetracycline derivative with similar antimicrobial activity.

OTHER

Placebo

Placebo

Trial Locations (7)

30303

RECRUITING

Grady Memorial Hospital, Atlanta

30308

RECRUITING

Emory University Hospital Midtown - Emory Clinic Infectious Diseases, Atlanta

35222

RECRUITING

University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham

14642-0001

RECRUITING

University of Rochester Medical Center - Vaccine Research Unit, Rochester

98104-2433

RECRUITING

University of Washington - Harborview Medical Center - Center for AIDS and STD, Seattle

Unknown

RECRUITING

Pwani Research Centre, Mombasa

RECRUITING

KEMRI-CCR PHRD Project, Thika

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH